The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 10, 2020

Filed:

Oct. 06, 2016
Applicants:

Fujirebio Inc., Tokyo, JP;

Sekisui Medical Co., Ltd., Tokyo, JP;

Inventors:

Yoshiyuki Kitamura, Tokyo, JP;

Katsumi Aoyagi, Tokyo, JP;

Assignees:

FUJIREBIO INC., Tokyo, JP;

SEKISUI MEDICAL CO., LTD., Tokyo, JP;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/573 (2006.01); G01N 33/53 (2006.01); C07K 16/36 (2006.01); C07K 16/40 (2006.01); C12N 15/02 (2006.01);
U.S. Cl.
CPC ...
G01N 33/573 (2013.01); C07K 16/36 (2013.01); C07K 16/40 (2013.01); C12N 15/02 (2013.01); G01N 33/53 (2013.01); G01N 33/5306 (2013.01); G01N 2333/96433 (2013.01);
Abstract

Disclosed is a means of enabling the construction of a more accurate PIVKA-II immunoassay system using monoclonal antibodies against human prothrombin. The PIVKA-II assay method according to the present invention comprises measuring PIVKA-II in a sample by an immunoassay using an anti-PIVKA-II antibody or an antigen-binding fragment thereof which specifically binds to PIVKA-II and a mixture of a first anti-prothrombin antibody or an antigen-binding fragment thereof which recognizes hydrophilic PIVKA-II molecules and a second anti-prothrombin antibody or an antigen-binding fragment thereof which recognizes hydrophobic PIVKA-II molecules.


Find Patent Forward Citations

Loading…